Genomic data from NSCLC tumors reveals correlation between SHP-2 activity and PD-L1 expression and suggests synergy in combining SHP-2 and PD-1/PD-L1 inhibitors

The identification of novel therapies, new strategies for combination of therapies, and repurposing of drugs approved for other indications are all important for continued progress in the fight against lung cancers. Antibodies that target immune checkpoints can unmask an immunologically hot tumor fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Toral, Keller J., Wuenschel, Mark A., Black, Esther P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389511/
https://www.ncbi.nlm.nih.gov/pubmed/34437586
http://dx.doi.org/10.1371/journal.pone.0256416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389511/
https://www.ncbi.nlm.nih.gov/pubmed/34437586
http://dx.doi.org/10.1371/journal.pone.0256416

Ejemplares similares